UK's MHRA Approves Quizartinib To Treat Adult Patients With

UK's MHRA Approves Quizartinib To Treat Adult Patients With Acute Myeloid Leukaemia

Daiichi Sankyo Co Ltd:
* ON MARCH 8, QUIZARTINIB APPROVED TO TREAT ADULT PATIENTS
WITH
ACUTE MYELOID LEUKAEMIA
Source text for Eikon:
Further company coverage:
...

Related Keywords

, Daiichi Sankyo Co Ltd , Reuters , Sankyo Co Ltd ,

© 2025 Vimarsana